Bailey R R, Bishop V, Peddie B, Chambers P F, Davies P R, Crofts H G
N Z Med J. 1983 Nov 23;96(744):970-2.
Augmentin was compared with co-trimoxazole for the treatment of uncomplicated urinary tract infections in general practice. All 28 patients randomly allocated to treatment with co-trimoxazole were cured. Of the 24 patients treated with augmentin 20(83%) were cured. The cure rate with co-trimoxazole was significantly greater (p = 0.039) than with augmentin. One patient treated with co-trimoxazole developed a skin rash. Two patients treated with augmentin developed severe diarrhoea and abdominal pain and a further two light-headedness. Two of the patients who failed augmentin treatment were reinfected with an augmentin-resistant organism. Twelve of the 52 pathogens were resistant to amoxycillin. One of these 12 was also resistant to augmentin and two only moderately sensitive. An additional three patients were excluded from the study because their infecting pathogen was resistant to augmentin. Augmentin would appear to have a place in the treatment of amoxycillin-resistant bacterial infections.
在普通医疗实践中,对阿莫西林克拉维酸钾(Augmentin)和复方新诺明治疗单纯性尿路感染进行了比较。随机分配接受复方新诺明治疗的28例患者全部治愈。接受阿莫西林克拉维酸钾治疗的24例患者中,20例(83%)治愈。复方新诺明的治愈率显著高于阿莫西林克拉维酸钾(p = 0.039)。1例接受复方新诺明治疗的患者出现皮疹。2例接受阿莫西林克拉维酸钾治疗的患者出现严重腹泻和腹痛,另有2例出现头晕。2例阿莫西林克拉维酸钾治疗失败的患者被对阿莫西林克拉维酸钾耐药的病原体再次感染。52种病原体中有12种对阿莫西林耐药。这12种中的1种也对阿莫西林克拉维酸钾耐药,2种仅中度敏感。另有3例患者被排除在研究之外,因为他们感染的病原体对阿莫西林克拉维酸钾耐药。阿莫西林克拉维酸钾似乎在治疗对阿莫西林耐药的细菌感染中占有一席之地。